The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes, the chairman of the Senate Finance Committee said Thursday.
But the data was not definitive, and Merck, which even critics say is one of the most responsible drug companies, repeatedly reassured the medical and financial communities that Vioxx was safe.
The two Merck & Co. executives were somber as the company plane pitched and rolled through the remnants of Hurricane Jeanne on the night of Sept. 28.

